Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-25

Clinical Trial Update: Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant XELOX chemotherapy (capecitabine and oxaliplatin) followed by surgery for advanced gastric cancer with para-aortic lymph no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eloxatin (oxaliplatin)
  • Xeloda (capecitabine)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Advanced Gastric Cancer | Phase 2 | Status: COMPLETED